NovaBay Pharmaceuticals, Inc.
Ticker: 1389545
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q3 FY23 | Q2 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 2.21-10.2% | 2.46+373.1% | 0.52-78.7% | 2.44+1.7% | 2.40-8.7% | 2.63-19.6% | 3.27-29.1% | 4.61 |
| Total Income | 2.21-10.2% | 2.46+373.1% | 0.52-78.7% | 2.44+1.7% | 2.40-8.7% | 2.63-19.6% | 3.27-29.1% | 4.61 |
| EXPENSES | ||||||||
| Expenditure | 56.05+382.7% | -19.83-1214.0% | 1.78-49.1% | 3.50+1.4% | 3.45-32.0% | 5.07+15.8% | 4.38-26.6% | 5.97 |
| Tax | -3.48-200.9% | 3.45 | 0.00 | — | — | — | — | — |
| PROFIT | ||||||||
| PBT | -44.55-108.0% | 555.86 | — | — | — | — | -1.76+13.7% | -2.04 |
| Net Profit | -41.07-107.4% | 552.40+42921.7% | -1.29-6.6% | -1.21+23.9% | -1.59+50.5% | -3.21-82.4% | -1.76+13.7% | -2.04 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-200.00pp | 100.00%+200.00pp | -100.00%-56.53pp | -43.47%+0.41pp | -43.88%+48.71pp | -92.59%-58.41pp | -34.18%-4.79pp | -29.39% |
| NPM % | -100.00%-200.00pp | 100.00%+200.00pp | -100.00%-50.35pp | -49.65%+16.39pp | -66.04%+33.96pp | -100.00%-46.19pp | -53.81%-9.65pp | -44.16% |
| EPS | -1.32-106.2% | 21.23+9750.0% | -0.22+63.3% | -0.60+56.2% | -1.37-813.3% | -0.15+59.5% | -0.37+70.9% | -1.27 |
Corporate Events
Board MeetingNBY
20262Sep
Board Meeting
David Garcia Rios appointed as a Class II director to the Bo…
SEC Filing ↗ Board MeetingNBY
202615Jul
Board Meeting
Chief Operating Officer Appointment — Henry Blynn appointed …
SEC Filing ↗